Novo Nordisk A/S

NONOFOTCHealthcare● Active

$41.25

$-2.11(-4.87%)

Market Cap$183.3B

P/E Ratio—

52W High$82.5

52W Low$34

Avg Volume185K

Open$42.84

Beta0.35

Net Income Financials Revenue

Novo Nordisk A/S (NONOF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

NONOF · net income · updated Jun 8, 2026

Core profitability metrics

NONOF · net income · margin · TTM · CAGR

Net income was $102.20B for FY2025 (fiscal year ending 2025-12-31), up 1.2% year-over-year. Net profit margin was 33.1%. Based on available data, Novo Nordisk A/S has been profitable since at least 2011.

FY2025 Net Income$102.20B▲ +1.2% YoY

Trailing 12M (TTM)$121.90Btrailing 4 quarters sum

Net Profit Margin33.1%$102.20B ÷ $308.36B

YoY Change+1.2%—

5-Year CAGR+19.4%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · NONOF net income history · NONOF profit margin

Annual net income data

NONOF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$102.20B▲ +1.2%33.1%$308.36B

FY2024$100.99B▲ +20.7%34.8%$290.40B

FY2023$83.68B▲ +50.7%36.0%$232.26B

FY2022$55.52B▲ +16.3%31.4%$176.95B

FY2021$47.76B▲ +13.3%33.9%$140.80B

Net income vs peers (Healthcare)

NONOF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Novo Nordisk A/SYOU

NONOF

$102.20B+1.2%33.1%

100%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

20%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Novo Nordisk A/S (NONOF) reported net income of $102.20B for FY2025 (fiscal year ending 2025-12-31), up 1.2% year-over-year. The net profit margin was 33.1% — meaning the company kept $0.33 of every dollar of revenue as profit.

Based on available data, Novo Nordisk A/S has been profitable since at least 2011. Net income reached a peak of $102.20B in FY2025. Data available for 15 fiscal years.

Novo Nordisk A/S's net profit margin was 33.1% for FY2025, based on the latest annual results.

Investors sometimes search for "Novo Nordisk A/S net worth" — the company's market capitalization is a separate figure from NONOF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

NONOF net income · 5 questions

Novo Nordisk A/S is profitable. The company reported net income of $102.20B for FY2025, a net profit margin of 33.1%. Net income was up 1.2% year-over-year. Based on available data, Novo Nordisk A/S has been profitable since at least 2011.

is NONOF profitabledoes NONOF make a profitNONOF profitabilityNONOF profitable company

▸ Source: FMP /income-statement · GAAP · Novo Nordisk A/S · Novo Nordisk A/S SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026